Loading page data

Please wait a moment

sales@persistencemarketresearch.com

Second Floor, 150 Fleet Street,
London, EC4A 2DQ.

+44 203-837-5656

108 W 39th Street, Ste 1006,
PMB2219, New York, NY 10018

+1 646-878-6329

IT Unit No. 504, 5th Floor, Icon
Tower, Baner, Pune - 411045.

+91 906 779 3500

Quick Links

Careers Terms & Conditions Return Policy Market Research Report

Customer FAQ’s Privacy Policy Sitemap

Our Partners

Secure Payments Through

Connect With Us -

Medical Devices
Biomaterials Market

Biomaterials Market Size, Share, Growth, and Regional Forecast, 2025 - 2032

Q: How big is the global biomaterials market?

The global biomaterials market was valued at US$ 112 Bn in 2021 and is expected to reach US$ 470 Bn by 2032.

Q: Which region is expected to dominate the global market?

North America accounts for over 38% share and is set to dominate the global biomaterials market going forward.

Biomaterials Market by Material (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, and Natural Biomaterials), by Application (Dental, Cardiovascular, Orthopedic, Wound Healing, Neurology, and Surgery), and Regional Analysis from 2025 - 2032

ID: PMRREP2781

November 2025

196 Pages

Author : Abhijeet Surwase

Healthcare

Key Industry Highlights:

Leading Region: North America leads the biomaterials market, driven by advanced healthcare infrastructure and technological innovation.
Fastest Growing Region: Asia Pacific is the fastest-growing region, enabled by expanded healthcare access, government initiatives, and local manufacturing strength.
Dominant Segment: The Metallic Biomaterials category dominates, accounting for a significant market share due to high clinical use and reliability in critical implants.
Fastest Growing Segment: Natural biomaterials driven by rising demand for bio-based, sustainable, and regenerative medical materials.

Key Insights	Details
Biomaterials Market Size (2025E)	US$186.3 Bn
Market Value Forecast (2032F)	US$436.1 Bn
Projected Growth (CAGR 2025 to 2032)	12.9%
Historical Market Growth (CAGR 2019 to 2024)	10.2%

global-biomaterials-market-size-2025-2032

Get Your CustomizationGet Your Customization

Market Dynamics

Driver - Rising Cardiovascular Disease Burden Drives Global Demand for Advanced Biomaterials Solutions

The increasing prevalence of cardiovascular disorders is exerting significant upward pressure on the global biomaterials market. According to the World Health Organization (WHO), an estimated 19.8 million people died from cardiovascular diseases (CVDs) in 2022, accounting for approximately 32% of all deaths worldwide. Major risk factors such as smoking, uncontrolled hypertension, physical inactivity, and elevated cholesterol levels are key drivers of this trend, leading to a growing burden of ischemic heart disease, stroke and other cardiac complications.

As the demand for advanced medical interventions continues to rise, biomaterials play a pivotal role in cardiac therapies, including heart valves, stents, vascular grafts, pacemakers and artificial hearts that restore and support damaged cardiovascular tissue. The combination of high clinical acceptance of such implantable devices and the expanding patient population requiring these solutions is fuelling market growth. Consequently, the surge in cardiovascular disease incidence worldwide is projected to drive robust demand for biomaterials over the coming years, making this an important strategic driver for the biomaterials market.

Restraints - Trade Policy and Supply Chain Challenges

Global trade policies and regulatory complexities pose significant restraints on the biomaterials market. Tariffs, cross-border restrictions, and shifting trade agreements, particularly between the U.S., Europe, and Asian manufacturing hubs, can lead to higher production costs and delayed material availability. Many advanced biomaterials, including medical-grade polymers, specialty metals, and bioceramics, rely on a limited number of specialized suppliers, making the industry vulnerable to supply disruptions. Changes in import-export regulations or customs procedures can slow the movement of critical components used in medical devices, implants, and research applications.

In addition, fluctuating raw material prices, transportation challenges, and dependence on overseas contract manufacturers create uncertainty for end users and developers. Stringent certification processes and varying standards across regions further complicate international distribution. These trade and supply chain issues can restrict innovation timelines, raise product costs, and hinder market expansion, particularly for small and mid-sized biomaterial producers with limited global logistics capabilities.

Opportunity - Smart Biomaterials and Digital Health Integration

The integration of smart biomaterials with digital health technologies is creating a transformative opportunity within the global biomaterials market. These advanced materials, embedded with sensors or responsive elements, can monitor biological changes, deliver drugs in a controlled manner, and adapt to patient-specific needs in real time. Growing adoption of AI and data analytics in healthcare is enabling the development of intelligent biomaterial systems capable of predicting healing responses and adjusting treatment regimens accordingly. Companies are increasingly collaborating across biotechnology, materials science, and digital health sectors to design personalized implants and regenerative therapies.

Partnerships between medical device manufacturers and technology firms are streamlining R&D processes, improving the accuracy of material testing, and accelerating regulatory approvals. For instance, digitally guided tissue scaffolds and sensor-based wound dressings offer superior clinical outcomes and reduced recovery times. As precision medicine gains traction, the convergence of smart biomaterials and digital health platforms is expected to redefine patient care, fostering long-term market growth and innovation leadership.

Category-wise Analysis

By Material Insights

Metallic biomaterials continue to dominate the global biomaterials market, accounting for approximately 32.5% of total revenue in 2024. Their exceptional mechanical strength, corrosion resistance, and long-term biocompatibility make them the preferred choice in orthopedic, dental, and cardiovascular implants. Titanium and its alloys, stainless steel, and cobalt-chromium remain the most widely used materials due to their proven performance in load-bearing applications such as hip, knee, and spinal implants. The growing number of trauma and reconstructive surgeries, coupled with advancements in surface modification technologies, is further driving demand.

On the other hand, natural biomaterials represent the fastest-growing segment, driven by the increasing preference for biologically derived and sustainable materials such as collagen, chitosan, and alginate. Their superior biocompatibility, bioactivity, and minimal immune response make them ideal for tissue regeneration, wound healing, and drug delivery. Expanding research in regenerative medicine and tissue engineering further accelerates their adoption across global healthcare systems.

By Application Insights

The orthopedic segment remains the largest application area within the biomaterials market, supported by a rising incidence of musculoskeletal disorders, sports injuries, and age-related bone degeneration. The growing elderly population in countries such as the U.S., Japan, and Germany has significantly increased the number of joint replacement procedures, particularly of the hip, knee, and shoulder joints. Technological advancements in metallic and polymeric biomaterials have improved prosthetic integration, wear resistance, and longevity, thereby enhancing patient mobility and reducing revision surgeries. The availability of bioresorbable fixation devices and porous coating for enhanced bone bonding further drives orthopedic applications.

Additionally, the rising prevalence of osteoporosis and trauma-related fractures in developing economies, along with improved access to healthcare, is boosting market penetration. Hospitals and specialized orthopedic centers are increasingly adopting biomaterial-based implants to shorten recovery time and improve outcomes. Continued innovation in 3D-printed orthopedic implants and regenerative bone graft substitutes ensures the segment’s sustained leadership in the biomaterials market.

global-biomaterials-market-outlook-by-material-2025-2032

Request Free sampleRequest Free sample

Region-wise Insights

North America Biomaterials Market Trends

North America dominates the global biomaterials market, accounting for around 38.3% of the total share in 2024. The region’s growth is underpinned by a well-established healthcare infrastructure, strong R&D investments, and early adoption of advanced medical technologies. The U.S. biomaterials market leads the North America market, driven by a high incidence of orthopedic and cardiovascular disorders, increasing demand for biodegradable implants, and strong collaborations among universities, biotech firms, and medical device companies. Key institutions such as the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) actively support innovation through grants and regulatory guidance. Canada also contributes significantly, with a growing focus on tissue engineering, regenerative medicine, and the manufacturing of polymeric biomaterials.

Additionally, rising investments by major players such as Stryker, Johnson & Johnson, and Zimmer Biomet in developing next-generation materials are propelling market expansion. The strong reimbursement framework and patient awareness about advanced implant solutions further reinforce North America’s market leadership.

Asia Pacific Biomaterials Market Trends

The Asia Pacific is witnessing the fastest growth in the global biomaterials market, driven by rising healthcare expenditures, an expanding patient base, and increasing local manufacturing capabilities. China leads the region, with strong government funding for biotechnology and regenerative medicine, along with the establishment of biomaterial innovation parks in cities such as Shanghai and Shenzhen. Japan continues to advance in nanomaterials and bioresorbable implants through collaborations between academic institutions and medical device firms.

India’s market is rapidly expanding, supported by the “Make in India” initiative and the rising production of cost-effective orthopedic and dental implants. South Korea and Singapore are investing in tissue engineering and smart biomaterials research to enhance medical export potential. The growing burden of chronic diseases, combined with favorable demographic trends and improved reimbursement frameworks, is driving adoption across orthopedics, cardiovascular care, and dentistry. Furthermore, international companies are increasingly partnering with regional manufacturers to capitalize on the Asia Pacific’s expanding healthcare ecosystem.

global-biomaterials-market-outlook-by-region-2025-2032

Competitive Landscape

The global biomaterials market is characterized by intense competition, with key players focusing on strategic collaborations, product innovations, and research partnerships to strengthen their market position. Leading companies are actively engaging in agreements and joint ventures to expand their product portfolios and accelerate the development of next-generation biomaterial-based implants and combination medical devices.

Strategic collaborations have become a defining trend, enabling companies to leverage each other’s technological strengths, R&D capabilities, and market reach. These alliances not only enhance product innovation but also drive greater adoption of biomaterials across medical applications such as orthopedics, cardiovascular care, and tissue engineering.

For example, in April 2022, GE Healthcare partnered with Medtronic to address the growing demand for treatment solutions in office-based laboratories (OBLs) and ambulatory surgery centers (ASCs). This collaboration offers customers integrated product portfolios, financing options, and comprehensive clinical support, highlighting how industry partnerships are reshaping the biomaterials landscape through value-driven innovation and expanded accessibility.

Key Industry Developments:

In September 2025, erthos®, a climate technology company focused on sustainable materials, announced a collaboration with Colgate-Palmolive to explore innovative eco-friendly packaging solutions through ZYA™, its AI-driven materials discovery platform.
In June 2024, Zimmer Biomet Holdings, Inc. announced a strategic initiative to launch next-generation biodegradable orthopedic implants.
In January 2023, Zimmer Biomet acquired Embody, Inc. to expand its sports medicine portfolio and enhance soft tissue healing solutions.

Companies Covered in Biomaterials Market

Evonik Industries AG
Medtronic plc
Carpenter Technology Corporation
Invibio Ltd.
Berkeley Advanced Biomaterials
BASF SE
Zimmer Biomet Holdings, Inc.
Stryker
Covalon Technologies Ltd.
Johnson & Johnson
Others

Frequently Asked Questions

The global biomaterials market was valued at US$ 112 Bn in 2021 and is expected to reach US$ 470 Bn by 2032.

The global market for biomaterials is expected to expand at a CAGR of 14.5% through 2032.

North America accounts for over 38% share and is set to dominate the global biomaterials market going forward.

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis	Value: US$ Bn and Volume (if Available)
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	By Material By Application By Region
Competitive Analysis	Evonik Industries AG Medtronic plc Carpenter Technology Corporation Invibio Ltd. Berkeley Advanced Biomaterials BASF SE Zimmer Biomet Holdings, Inc. Stryker Covalon Technologies Ltd. Johnson & Johnson Others
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Market Analysis Tools

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading Report...

Medical Devices
Biomaterials Market